Psychosomatic aspects of Cushing's disease

Psychotherapy and Psychosomatics

Volumn 67, Issue 3, 1998, Pages 140-146

  Sonino, Nicoletta ^a   Fava, Giovanni A ^b,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anxiety; Cushing's disease; Depression; Hypercortisolemia; Quality of life; Residual symptoms; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOCORTICOID; HYDROCORTISONE;

CUSHING DISEASE; DEPRESSION; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIFE EVENT; PSYCHOBIOLOGY; PSYCHOSOMATICS; QUALITY OF LIFE; RELAPSE; REVIEW;

ANXIETY; CUSHING SYNDROME; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PSYCHOPHYSIOLOGIC DISORDERS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 0031864982     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012274     Document Type: Review

References (67)

1. Sonino N: From the lesson of Harvey Cushing to current knowledge: Psychosocial aspects of endocrine disease. Psychother Psychosom 1997; 66:113-116.
2. Pava GA, Sonino N, Morphy MA: Major depression associated with endocrine disease. Psychiatr Dev 1987;4:321-348.
3. Fava GA, Sonino N, Morphy MA: Psychosomatic view of endocrine disorders. Psychother Psychosom 1993;59:20-33.
4. Starkman MN: The HPA axis and psychopathology: Cushing's syndrome. Psychiatr Ann 1993;23:691-701.
5. Gushing H: Psychic disturbances associated with disorders of the ductless glands. Am J Insanity 1913;69:965-990.
6. Trethowan WH, Cobb S: Neuropsychiatrie aspects of Cushing's syndrome. AMA Arch Neurol Psychiatry 1952;67:283-309.
7. Gifford S, Gunderson JG: Cushing's disease as a psychosomatic disorder. Medicine 1970;49: 397-409.
8. Cohen SI: Cushing's syndrome. A psychiatric study of 29 patients. Br J Psychiatry 1988:120-124.
9. Sonino N, Fava GA, Grandi S, Mantero F, Boscaro M: Stressful life events in the pathogenesis of Cushing's syndrome. Clin Endocrinol 1988; 29:617-623.
10. Sonino N, Fava GA, Boscaro M: A role for life events in the palhogenesis of Cushing's disease. Clin Endocrinol 1993;38:261-264.
11. Paykel ES: The Interview for Recent Life Events. Psychol Med 1997;27:301-310.
12. Mazet Ph, Simon D, Luton JP, Bricaire H: Syndrome de Cushing: Symptomatologie psychique et personalité de 50 malades. Nom Presse Méd 1988;10:2565-2570.
13. Fava GA, Munari F, Pavan L, Kellner R: Life events and depression. J Affect Disord 1981;3: 159-165.
14. Kelly WF: Psychiatrie aspects of Cushings syndrome. Q J Med 1996;89:543-551.
15. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA: Life events in the pathogenesis of Graves' disease. Acta Endocrinol 1993; 128:293-296.
16. Radosavljevic VR, Jankovic SN, Marinkovic JM: Stressful life events in the pathogenesis of Graves' disease. Eur J Endocrinol 1996;134: 699-701.
17. Kung AWC: Life events, daily stresses and coping in patients with Graves' disease. Clin Endocrinol 1995;42:303-308.
18. Krieger DT: Physiopathology of Cushing's disease. Endocr Rev 1983;4:22-43.
19. Harbuz MS, Lightman SL: Stress and the hypothalamo-pituitary-adrenal axis. J Endocrinol 1992;134:327-339.
20. Leonard BE: Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother Psychosom 1996;65:66-75.
21. Sonino N, Fava GA: Serotonin, Cushing's disease and depression. Psychother Psychosom 1996;65:63-65.
22. de Kloel ER, Rots NY, Cools AR: Brain-corticosteroid hormone dialogue: Slow and persistent. Cell Mol Neurobiol 1996;16:345-356.
23. Sonino N, Ziclezny M, Fava GA, Fallo F, Boscaro M: Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81:2647-2652.
24. Sonino N, Boscaro M, Fallo F, Fava GA: Potential therapeutic effects of ritanserin in Cushing's disease. JAMA 1992;267:1073.
25. Sonino N: The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987; 317:812-818.
26. Biondi M, Picardi A: Clinical and biological aspects of bereavement and loss-induced depression: A reappraisal. Psychother Psychosom 1996;65:229-245.
27. Biondi M. Zannino LG: Psychological stress. neuroimmunomodulation, and susceptibility to infectious diseases in animals and man. Psychother Psychosom 1997;66:3-26.
28. Heim C, Owens MJ, Plotsky PM, Nemeroff CB: Persistent changes in corticotropin-releasing factor systems due to early life stress. Psychopharmacol Bull 1997;33:185-192.
29. Burgess E, Dorn LD, Haaga DAF, Chrousos G: Sociotropy, autonomy, stress, and depression in Gushing syndrome. J Nerv Ment Dis 1996; 184:362-367.
30. Sonino N, Fava GA, Fallo F, Boscaro M: Psychological distress and quality of life in endocrine disease. Psychother Psychosom 1990;54: 140-144.
31. Whitlock FA: Symptomatic Affective Disorders. Sydney, Academic Press, 1982.
32. Haskett RF: Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 1985;142:911-916.
33. Hudson JI, Hudson MS, Griding GT, Melby JC, Pope HG: Phenomenology and family history of affective disorder in Cushing's disease. Am J Psychiatry 1987;144:951-953.
34. Loosen PT, Chambliss B, de Bold CR, Shelton R, Orth DN: Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry 1992;25: 192-198.
35. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M: Course of depression in Cushing's syndrome: Response to treatment and comparison with Graves' disease. Horm Res 1993;39: 202-206.
36. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F: Clinical correlates of major depression in Cushing's disease. Psychopathology. in press.
37. Fava GA: Affective disorders and endocrine disease. Psychosomatics 1994;35:341-353.
38. Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, Gold PW, Chrousos GP: Psychopathology in patients with endogenous Cushing's syndrome: Atypical or melancholic features. Clin Endocrinol 1995;43:433-442.
39. Fava GA, Sonino N: Depression associated with medical illness. CNS Drugs 1996;5:175-189.
40. Starkman MN, Schteingart DE, Schork MA: Depressed mood and other psychiatric manifestations of Cushing's syndrome. Psychosom Med 1981;43:3-18.
41. Lam RW, Stewart JN: The validity of atypical depression in DSM-IV. Comp Psychiatry 1996; 37:375-383.
42. Starkman MN, Schteingart DE, Schork MA: Correlation of bedside cognitive and neuropsychological tests in patients with Cushing's syndrome. Psychosomatics 1986;27:508-511.
43. Schrader GD: Subjective and objective assessments of medical comorbidity in chronic depression. Psychother Psychosom 1997;66:258-260.
44. Fava GA: Screening and diagnosis of depression. Dis Manage Health Outcomes 1997;2:1-7.
45. Ryff CD, Singer B: Psychological well-being. Psychother Psychosom 1996;65:14-23.
46. Bech P, Gudex C, Staher-Johansen K: The WHO (Ten) Well-Being Index: Validation in diabetes. Psychother Psychosom 1996;65:183-190.
47. Armstrong A: The phenomenology of Cushing's syndrome: One patient's account. Henry Ford Hosp Med J 1991;39:8-9.
48. Regenstein QR, Rose LI, Williams GH: Psychopathology in Cushing's syndrome. Arch Intern Med 1972;130:114-117.
49. Jeffcoate WJ, Silverstone JT, Edwards CRW, Besser GM: Psychiatric manifestations of Cushing's syndrome: Response to lowering of plasma cortisol. QJ Med 1979;48:465-472.
50. Kramlinger KG, Peterson GC, Watson PK, Leonard LL: Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics 1985;26:67-71.
51. Kelly WF, Kelly MJ, Faragher B: A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol 1996; 45;715-720.
52. Sonino N, Boscaro M, Ambrose G, Merola G, Mantero F: Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Med Sci 1986;14:485-486.
53. Starkman MN, Schteingart DE, Schork MA: Cushing's syndrome after treatment. Psychiatry Res 1986;17:177-178.
54. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP: The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997;82:912-919.
55. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R: Memory impairment in Cushing's disease. Acta Neurol Scand 1993; 87:52-55.
56. Starkman MN, Gebarski SS, Berent S, Schteingart DE: Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756-765.
57. Momose KJ. Kjellberg RN, Kliman B: High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Radiology 1971;99:341-348.
58. Dubrovsky B: Effects of adrenal cortex hormones on limbic structures. J Psychiatr Neurosci 1993;18:4-16.
59. Fava GA: The concept of recovery in affective disorders. Psychother Psychosom 1996;65:2-13.
60. Wilcox JA: Pituitary microadenoma presenting as panic attacks. Br J Psychiatry 1991;158:426-427.
61. Manu P, Affleck G, Tennen H, Morse PA, Escobar JI: Hypochondriasis influences quality of life outcomes in patients with chronic fatigue. Psychother Psychosom 1996;65:76-81.
62. Voigt KH, Bossert S, Bretschneider S, Bliestle A, Fehm HL: Disturbed cortisol secretion in man. Psychiatry Res 1985;15:341-350.
63. Taft P, Martin FIR, Melick R: Cushing's syndrome. A review of the response to treatment in 42 patients. Australs Ann Med 1970;4:295-303.
64. Fava GA, Sonino N: Hypothalamic-pituitary-adrenal axis disturbances in depression. IRCS Med Sci 1986;14:1058-1060.
65. Patten SB, Love EJ: Drug-induced depression. Psychother Psychosom 1997;66:63-73.
66. Sonino N, Fallo F, Opocher G, Boscaro M: Hypertension in Cushing's syndrome. Med Sci Res 1992;20:431-434.
67. Fallo F, Sonino N, Barzon L, Pistorello M, Pagotto U, Paoletta A, Boscaro M: Effects of surgical treatment on hypertension in Cushing's syndrome. Am J Hypertens 1996;9:77-80.